Prestige Consumer Healthcare ROA 2010-2024 | PBH
Current and historical return on assets (ROA) values for Prestige Consumer Healthcare (PBH) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Prestige Consumer Healthcare ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-09-30 | $0.21B | $3.32B | 6.17% |
| 2024-06-30 | $0.21B | $3.31B | 6.17% |
| 2024-03-31 | $0.21B | $3.32B | 6.27% |
| 2023-12-31 | $-0.08B | $3.34B | -2.42% |
| 2023-09-30 | $-0.08B | $3.33B | -2.38% |
| 2023-06-30 | $-0.09B | $3.35B | -2.41% |
| 2023-03-31 | $-0.08B | $3.35B | -2.30% |
| 2022-12-31 | $0.21B | $3.75B | 5.68% |
| 2022-09-30 | $0.21B | $3.68B | 5.66% |
| 2022-06-30 | $0.20B | $3.68B | 5.50% |
| 2022-03-31 | $0.21B | $3.67B | 5.63% |
| 2021-12-31 | $0.19B | $3.66B | 5.28% |
| 2021-09-30 | $0.18B | $3.68B | 5.09% |
| 2021-06-30 | $0.18B | $3.56B | 5.18% |
| 2021-03-31 | $0.17B | $3.43B | 4.82% |
| 2020-12-31 | $0.17B | $3.47B | 4.82% |
| 2020-09-30 | $0.16B | $3.43B | 4.73% |
| 2020-06-30 | $0.15B | $3.45B | 4.38% |
| 2020-03-31 | $0.14B | $3.51B | 4.09% |
| 2019-12-31 | $-0.03B | $3.46B | -0.98% |
| 2019-09-30 | $-0.03B | $3.47B | -0.97% |
| 2019-06-30 | $-0.04B | $3.46B | -1.01% |
| 2019-03-31 | $-0.04B | $3.44B | -0.99% |
| 2018-12-31 | $0.06B | $3.67B | 1.69% |
| 2018-09-30 | $0.34B | $3.70B | 8.99% |
| 2018-06-30 | $0.34B | $3.77B | 8.87% |
| 2018-03-31 | $0.34B | $3.76B | 8.80% |
| 2017-12-31 | $0.39B | $3.90B | 10.02% |
| 2017-09-30 | $0.11B | $3.90B | 2.97% |
| 2017-06-30 | $0.11B | $3.90B | 3.24% |
| 2017-03-31 | $0.07B | $3.91B | 2.22% |
| 2016-12-31 | $0.07B | $2.81B | 2.51% |
| 2016-09-30 | $0.07B | $2.83B | 2.41% |
| 2016-06-30 | $0.07B | $2.88B | 2.45% |
| 2016-03-31 | $0.10B | $2.95B | 3.69% |
| 2015-12-31 | $0.11B | $2.64B | 4.17% |
| 2015-09-30 | $0.10B | $2.63B | 3.89% |
| 2015-06-30 | $0.09B | $2.64B | 3.26% |
| 2015-03-31 | $0.08B | $2.64B | 3.15% |
| 2014-12-31 | $0.07B | $2.68B | 3.09% |
| 2014-09-30 | $0.05B | $2.73B | 2.52% |
| 2014-06-30 | $0.07B | $1.85B | 3.77% |
| 2014-03-31 | $0.07B | $1.80B | 4.05% |
| 2013-12-31 | $0.08B | $1.87B | 4.25% |
| 2013-09-30 | $0.09B | $1.81B | 4.85% |
| 2013-06-30 | $0.07B | $1.74B | 4.06% |
| 2013-03-31 | $0.07B | $1.74B | 3.71% |
| 2012-12-31 | $0.05B | $1.73B | 2.62% |
| 2012-09-30 | $0.04B | $1.79B | 2.77% |
| 2012-06-30 | $0.04B | $1.75B | 2.71% |
| 2012-03-31 | $0.04B | $1.76B | 3.10% |
| 2011-12-31 | $0.04B | $1.05B | 4.18% |
| 2011-09-30 | $0.04B | $1.06B | 3.42% |
| 2011-06-30 | $0.03B | $1.05B | 3.44% |
| 2011-03-31 | $0.03B | $1.06B | 3.15% |
| 2010-12-31 | $0.03B | $1.05B | 3.05% |
| 2010-09-30 | $0.04B | $0.79B | 4.45% |
| 2010-06-30 | $0.03B | $0.78B | 4.31% |
| 2010-03-31 | $0.03B | $0.79B | 4.03% |
| 2009-12-31 | $-0.18B | $0.79B | -22.86% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.893B | $1.125B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $221.767B | 27.38 |
| Boston Scientific (BSX) | United States | $151.377B | 43.52 |
| Stryker (SYK) | United States | $149.082B | 32.08 |
| EssilorLuxottica (ESLOY) | France | $125.055B | 0.00 |
| Medtronic (MDT) | Ireland | $117.214B | 17.41 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.950B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.139B | 28.03 |
| GE HealthCare Technologies (GEHC) | United States | $40.136B | 20.82 |
| ResMed (RMD) | United States | $37.119B | 30.50 |
| Terumo (TRUMY) | Japan | $28.886B | 41.07 |
| Koninklijke Philips (PHG) | Netherlands | $25.642B | 19.63 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.107B | 14.07 |
| Insulet (PODD) | United States | $19.438B | 77.40 |
| Baxter (BAX) | United States | $16.737B | 10.89 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.065B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.084B | 40.57 |
| Sunny Optical Technology (SNPTF) | China | $9.976B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.966B | 33.87 |
| Demant (WILYY) | Denmark | $8.735B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.433B | 14.95 |
| ICU Medical (ICUI) | United States | $4.121B | 39.23 |
| Envista Holdings (NVST) | United States | $3.678B | 27.40 |
| Haemonetics (HAE) | United States | $3.430B | 16.74 |
| Perrigo (PRGO) | Ireland | $3.366B | 9.91 |
| GN Store Nord (GNNDY) | Denmark | $3.027B | 19.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.927B | 18.84 |
| Neogen (NEOG) | United States | $2.495B | 28.75 |
| LeMaitre Vascular (LMAT) | United States | $2.247B | 54.60 |
| AtriCure (ATRC) | United States | $2.067B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.464B | 25.63 |
| InMode (INMD) | Israel | $1.462B | 8.79 |
| AdaptHealth (AHCO) | United States | $1.430B | 10.22 |
| BioLife Solutions (BLFS) | United States | $1.313B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.270B | 0.00 |
| Owens & Minor (OMI) | United States | $1.150B | 8.99 |
| Evolus (EOLS) | United States | $0.922B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.887B | 15.64 |
| CeriBell (CBLL) | United States | $0.833B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.830B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.649B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.561B | 24.73 |
| Surmodics (SRDX) | United States | $0.511B | 0.00 |
| Omeros (OMER) | United States | $0.502B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.429B | 0.00 |
| Valneva SE (VALN) | France | $0.412B | 0.00 |
| ZimVie (ZIMV) | United States | $0.401B | 33.77 |
| Quanterix (QTRX) | United States | $0.370B | 0.00 |
| Cerus (CERS) | United States | $0.360B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.322B | 30.67 |
| Sanara MedTech (SMTI) | United States | $0.317B | 0.00 |
| Biote (BTMD) | United States | $0.309B | 6.76 |
| OraSure Technologies (OSUR) | United States | $0.291B | 19.50 |
| Canopy Growth (CGC) | Canada | $0.265B | 0.00 |
| Zynex (ZYXI) | United States | $0.263B | 55.13 |
| High Tide (HITI) | Canada | $0.239B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.233B | 3.28 |
| Utah Medical Products (UTMD) | United States | $0.208B | 15.52 |
| Aurora Cannabis (ACB) | Canada | $0.203B | 0.00 |
| Brainsway (BWAY) | Israel | $0.197B | 104.70 |
| MacroGenics (MGNX) | United States | $0.190B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.189B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.154B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 18.27 |
| Quipt Home Medical (QIPT) | United States | $0.135B | 0.00 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| Fonar (FONR) | United States | $0.102B | 11.54 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| InterCure (INCR) | Israel | $0.077B | 0.00 |
| Exagen (XGN) | United States | $0.072B | 0.00 |
| INLIF (INLF) | $0.071B | 0.00 | |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Modular Medical (MODD) | United States | $0.051B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.050B | 14.35 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |